Clinical Trials Directory

Trials / Unknown

UnknownNCT03085342

Evaluation of Hepatic Fibrosis on Multiparametric MRI

Evaluation of Hepatic Fibrosis on Multiparametric MRI Including Portal Flow Measurement Using Dual-input Software: Preliminary Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

As cirrhosis progresses, alteration of hemodynamics develops and decreased portal flow is often observed. Since direct measurement of portal pressure (HVPG) is invasive, non-invasive methods have drawn a lot of attention. MRI is one of the non-invasive methods and it is able to provide multiparametric data in one examination. Herein, we evaluate hepatic fibrosis with different stage using multiparametric MRI with emphasis on portal flow measurement.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLiver MRIMultiparametric Liver MRI including following sequences: DCE, DWI, MRE, precontrast flow measurement, fat quantification.

Timeline

Start date
2017-04-04
Primary completion
2019-09-25
Completion
2021-12-01
First posted
2017-03-21
Last updated
2020-10-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03085342. Inclusion in this directory is not an endorsement.

Evaluation of Hepatic Fibrosis on Multiparametric MRI (NCT03085342) · Clinical Trials Directory